Implanon (contraceptive implant) – lines to take and q&a

IMPLANON (contraceptive implant) – Lines to take and Q&A: from
the Department of Health Sexual Health Team.
Top Lines
DH spokesperson
"We understand why women are concerned. They should be reassured
that the vast majority of people with the implants experience safe and
effective care.
"The implant is one of the most reliable forms of contraception. It is over
99 % effective and less than one woman in every 1,000 will get pregnant
over three years. However, no method is 100% effective and women
should be informed of the risk of pregnancy as part of any discussion
around contraception. It is essential that all health professionals who
insert implants should have received appropriate training and
certification. To put this in context, we estimate that around 800,000
women currently use Implanon, and that around 1.4 million women have
used Implanon since it was first licensed in 1999."
On compensation
"If something goes wrong, hospitals have a duty to report it and it is right
that patients are compensated where appropriate. It is essential that all
health professionals who insert implants should have received appropriate
training and certification and if they don't, doctors and nurses can find
themselves up before GMC or nursing and midwifery council for poor
practice."
Q&A

What is Implanon and how does it work?
The Implanon contraceptive implant is a small flexible rod that is placed just under the skin of the upper arm. It releases a progestogen hormone similar to the natural progesterone that women produce in their ovaries. It works for up to three years. What training do doctors and nurses need to fit Implanon?
All doctors offering Implanon insertion should hold the Letter of
Competence in Subdermal Contraceptive Implants (LoC SDI) from the
Faculty of Sexual and Reproductive Healthcare (FSRH).
Nurses should obtain accreditation from the Royal College of Nursing
(RCN) after completion of the RCN training guidance.
Accreditation involves: demonstration of skills required for counselling
for implants, knowledge of issues relevant to implant use, problem
management, and observation of insertion and removal. In addition, a
minimum number of supervised insertions and removals, as specified by
the FSRH/RCN should be completed.
Evidence of maintaining skills should be sought by recertifying according
to the FSRH/RCN guidelines and attending regular updates.
What is the Department doing to promote training etc?

The Faculty of Sexual and Reproductive Healthcare has very strict rules
in place about the training and revalidation that must be undertaken. In
promoting choice in contraception, the Department has worked closely
with the Faculty to increase training opportunities for health professionals
to train to fit and remove LARC methods safely.
The Department has invested £33m over 3 years in the Improving Access
to Contraception Fund (which included a number of LARC training and
access projects). The figures also include amounts for work in Further
Education colleges:
2008/09 - £10m
2009/10 - £11.6m
2010/11 - £11.4m
Total across the 3 years - £33m
No health professional should be doing procedures which they are not
trained and competent to undertake - this includes implant insertion and
removal. If they don't have the appropriate training then women can sue
for negligence and doctors and nurses can find themselves up before
GMC or nursing and midwifery council for poor practice.
How many women use Implanon?

We estimate that around 800,000 women currently use Implanon, and that
around 1.4 million women have used Implanon since it was first licensed
in 1999. The number of women using Implanon has increased in recent
years.
No method of contraception is 100% effective all of the time. Implanon is
99% effective, and the small number of unintended pregnancies
mentioned in the article therefore needs to be seen in the context of the
large number of women who have successfully used Implanon to help
them to manage their fertility.
How many women use contraception
Survey data shows that 58% of women aged 16-49 use some form of
contraception. Around 3 million women use the pill and a similar number
use male condoms.
How effective is Implanon? And what about failures?

Implanon is over 99% effective. It is particularly effective because once it
is fitted users do not need to take any further action themselves – unlike
the pill, which users need to remember to take every day, or a condom,
which users must use correctly every time they have sex.
But no method of contraception is 100% effective in every case. Doctors
and nurses will need to discuss the possibilities of contraceptive failure
with their patients to help them to come to a decision about which method
of contraception is right for them.
How common is it for compensation to be paid on implanon?

It is rare. NHS litigation authority has only ever had 14 claims, and we
are aware of a few others through the Medical Defence organisations, but
that is in the context of 1.4 million women having used this drug. So
people should be reassured that in the vast majority of cases, people
experience good care.
How much has been paid out?

From the NHS Litigation Authority, via FOI on 11 Nov.
£200,000. £118,583 was paid in damages £80,000 is related to costs.
This relates to 9 cases. There have only ever been 14 claims through NHS
LA, and again, this is in the context of 1.4million women having used this
drug.
Other problems/side effects with Implanon
Some women can experience side effects when using Implanon, such as
changes in periods and some can experience prolonged bleeding just after
the implant has been inserted. Women should be advised of any possible
side effects before an implant is inserted, and advised to return to for a
further discussion with their doctor or nurse if they experience any
problems with side effects.
There are fifteen different methods of contraception, and not all of them
will be suitable for everyone. However, doctors and nurses will be able to
advise patients on a method which is suitable for them.
Problems with removal/scaring of skin
No procedure is risk free but these are rare events.

Why has the Department been promoting Implanon – and other
long-acting reversible contraception – if it doesn’t work properly?

There are fifteen different methods of contraception, and the Department
is keen to promote contraceptive choice. We are keen to make sure that
women are aware that contraceptive choice goes beyond condoms and the
pill, and that they are aware of other options such as long-acting
reversible contraceptives, such as Implanon.
What is the difference between Implanon and Nexplanon?

Nexplanon replaced Implanon from October 2010. Nexplanon consists of
a new delivery system which makes it easier for trained doctors and
nurses to fit the implant correctly. Both Implanon and Nexplanon are
identical in terms of how they work and their effectiveness, so there will
be no need for Implanon users to have their implant replaced by
Nexplanon before its normal replacement time.
What should users do if they have any concerns?
Anyone who wants to talk about contraception – whether they currently use Implanon or not – can talk to their GP or to a healthcare professional at their local community sexual health clinic.

Source: http://luvhull.co.uk/assets/Uploads/Implanon-briefing.pdf

Tx1263-1.qxd

WARNINGS: Rarely, severe and occasionally fatal allergic reactions have been reported TAGITOL V following administration of barium sulfate contrast agents. Such a reaction can occur up BARIUM SULFATE SUSPENSION to 60 minutes following administration. (40% w/v, 30% w/w) Allergic reactions are more likely to occur inindividuals with a history of allergic reactionsto barium sulfate produ

manzwaterinfo.ca

April 22, 2004 Rotary Club: Bob Hildreth, Rob Overly, Jim Bodenner CDC/FDDB: Rob Quick, Eric Mintz Professor Mark Sobsey Daniele Lantagne, PE (dul4@cdc.gov) Environmental Engineer Foodborne and Diarrheal Diseases Branch Centers for Disease Control and Prevention Subject: Trip Report – Dominican Republic I. Dates and Places of Travel 27 February – March 3: Puer

© 2010-2018 PDF pharmacy articles